Convalescent plasma for covid19 – how long should a donor be excluded from donation?

Convalescent plasma (CP) has been used to treat emerging diseases in the past, and despite its empirical use, the results were positive and now has been tested for COVID19.1,2 The FDA (Food and Drug Administration, USA) the EC (European Commission, Belgium) and other regulatory agencies have authorized the use of CP from patients with resolved COVID19 with different regulations.3,4 Clinical and laboratory criteria are basically defined by the evidence of SARS-CoV-2 documented by clinical and/or laboratory evidence, and 14 to 28 days of resolution of symptoms prior to donation.

Source: Transfusion and Apheresis Science - July 13, 2020 Category: Hematology Authors: Jose M Kutner, Carolina Bonet-Bub, Ana Paula H Yokoyama, Araci M Sakashita, Joao R R Pinho, Nelson Hamerschlak, Luis V Rizzo Tags: Letter to the Editor Source Type: research